Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

Metabolic Reprogramming of Cancer-Associated Fibroblast in the Tumor Microenvironment: from Basics to Clinic

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

Metabolic Rewiring in Cancer-Associated Fibroblasts Provides a Niche for Oncogenesis and Metastatic Dissemination

The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives

Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors

Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Unlocking the Crucial Role of Cancer-Associated Fibroblasts in Tumor Metastasis: Mechanisms and Therapeutic Prospects

Metabolic Reprogramming of the Tumour Microenvironment

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures

Lipid Metabolic Reprogramming in Tumor Microenvironment: from Mechanisms to Therapeutics

Cancer-associated fibroblasts: from basic science to anticancer therapy

[Advancement of Relationship Between Metabolic Alteration in Cancer-Associated Fibroblasts and Tumor Progression in Lung Cancer].

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Metabolic reprogramming, sensing, and cancer therapy

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers